Novartis is trading at $151.32, up 3.02%, with healthcare-sector strength the main context for the gain.
- On October 15, healthcare reportedly rose 2.12%; coverage also cited a defensive rotation into healthcare in the prior session.
- Novartis announced a $1.1 billion San Diego research-centre project on October 15, but available reporting does not establish it as the cause.
- Markets are mixed: the Nasdaq is lower and the Dow higher; no clear company-specific catalyst is confirmed.